GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NKGen Biotech Inc (NAS:NKGN) » Definitions » Other Stockholders Equity

NKGen Biotech (NKGen Biotech) Other Stockholders Equity : $-10.39 Mil (As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is NKGen Biotech Other Stockholders Equity?

NKGen Biotech's Other Stockholders Equity for the quarter that ended in Mar. 2024 was $-10.39 Mil.

NKGen Biotech's quarterly Other Stockholders Equity increased from Sep. 2023 ($-32.92 Mil) to Dec. 2023 ($-18.29 Mil) and increased from Dec. 2023 ($-18.29 Mil) to Mar. 2024 ($-10.39 Mil).

NKGen Biotech's annual Other Stockholders Equity declined from Dec. 2021 ($0.00 Mil) to Dec. 2022 ($-0.00 Mil) and declined from Dec. 2022 ($-0.00 Mil) to Dec. 2023 ($-18.29 Mil).


NKGen Biotech Other Stockholders Equity Historical Data

The historical data trend for NKGen Biotech's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NKGen Biotech Other Stockholders Equity Chart

NKGen Biotech Annual Data
Trend Dec21 Dec22 Dec23
Other Stockholders Equity
- - -18.29

NKGen Biotech Quarterly Data
Dec21 Sep22 Dec22 Mar23 Sep23 Dec23 Mar24
Other Stockholders Equity Get a 7-Day Free Trial - - -32.92 -18.29 -10.39

NKGen Biotech Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity


NKGen Biotech Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of NKGen Biotech's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


NKGen Biotech (NKGen Biotech) Business Description

Traded in Other Exchanges
N/A
Address
19700 Fairchild Road, Suite No. 300, Irvine, CA, USA, 92612
NKGen Biotech Inc is a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous, allogeneic and CAR-NK natural killer cell therapies utilizing our proprietary SNK (super-activated) platform.